ARKG vs PGX

ARK Genomic Revolution ETF vs Invesco Preferred ETF

Quick take
  • • PGX has the lower expense ratio at 0.50% vs 0.75% for ARKG.
  • • PGX pays a higher dividend yield (6.96%).

Side-by-side metrics

MetricARKGPGX
Expense ratio
Annual fee. Lower is better.
0.75%0.50%
Dividend yield
Trailing 12-month yield.
0.00%6.96%
AUM
Assets under management — bigger funds are typically more liquid.
$2.21B$3.55B
YTD return
66.55%-5.76%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
2.111.08
P/E ratio
——
Last price
$47.17$9.88
Inception
——
Issuer
ARKInvesco

ARKG top holdings

Top holdings · ARKG
TWSTTwist Bioscience Corp8.75%
TXG10x Genomics Inc Ordinary Shares - Class A8.73%
TEMTempus AI Inc Class A common stock8.36%
ABSIAbsci Corp5.56%
CRSPCRISPR Therapeutics AG5.22%
GHGuardant Health Inc4.88%
NTRANatera Inc4.71%
ILMNIllumina Inc4.69%
LLYEli Lilly and Co3.92%
BEAMBeam Therapeutics Inc3.69%
Sector breakdown · ARKG
Healthcare100.0%

PGX top holdings

Holdings data unavailable for PGX.
Sector breakdown · PGX
Utilities100.0%

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About PGX

PGX (Invesco Preferred ETF) is US investment-grade preferred stocks. Managed by Invesco, the fund carries $3.5B in assets under management, an expense ratio of 0.50%, a dividend yield of 6.96%. Utilities is the fund's largest sector exposure at 100.0%.